Prednisone modified release - Sun Pharmaceutical IndustriesAlternative Names: Prednisone MR - Sun Pharmaceutical Industries
Latest Information Update: 15 Sep 2016
At a glance
- Originator Sun Pharmaceutical Industries
- Class Anti-inflammatories; Antiallergics; Antineoplastics; Antirheumatics; Corticosteroids; Glucocorticoids; Pregnadienediols; Small molecules
- Mechanism of Action Glucocorticoid receptor agonists; Immunosuppressants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Rheumatoid arthritis
Most Recent Events
- 12 Sep 2016 Sun Pharma Laboratories plans a phase III trial for Rheumatoid arthritis (Treatment-experienced) in India (PO) (CTRI2016-04-006821)
- 13 Apr 2016 Clinical trials in Rheumatoid arthritis in India (PO) before April 2016